As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

The BIRAC funding will enable comprehensive toxicology assessments, a necessary step in preparing for IND submission with ...

DelveInsight's "TEPMETKO Market Size, Forecast, and Market Insight Report" highlights the details around TEPMETKO, a kinase ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...

CStone Pharmaceuticals ('CStone', HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the first patient ...

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...